関連する実験動画
Updated: May 9, 2026

07:40
Multi-Modal Home Sleep Monitoring in Older Adults
Published on: January 26, 2019
"組み込み製薬化"を理解する:晩年の睡眠薬の使用に関するケーススタディ
Georgia Smith1, Hannah Farrimond1
1University of Exeter, UK.
Health (London, England : 1997)
|February 12, 2026
まとめ
長期にわたる睡眠薬の使用は,睡眠に対する深い感情的必要性,圧倒的な懸念のために,高齢者に持続します. これは これは これは これは これは
科学分野:
- 社会学 社会学 社会学とは
- ゲロントロジーはゲロントロジーの学科です.
- 薬学研究 薬学研究
背景:
- 高齢者の睡眠薬の使用は,転倒や認知機能低下などの副作用と関連しています.
- 処方量を減らすためのガイドラインにもかかわらず,高齢者の間で長期使用は依然として一般的です.
- 社会学的な研究は,後の生活における睡眠補助剤依存に関する曖昧さと不安を明らかにしています.
研究 の 目的:
- 高齢者の睡眠薬の持続的な長期使用の背後にある理由を探求する.
- 睡眠薬の使用が高齢者の生活にどのように組み込まれているかを理解する.
- 感情的ニーズ,必要と認識され,睡眠補助剤への継続的な依存の相互作用を調査する.
主な方法:
- イギリスの65歳以上の38人の成人のインタビューと日記を対象とした定性研究.
- 参加者の睡眠薬の平均使用期間は17年であった.
- 分析は,懸念を表明したにもかかわらず,使用の持続性を理解することに焦点を当てました.
主要な成果:
- 参加者は道徳的な懸念を表明したが,睡眠に対する深い感情的必要性を優先した.
- 睡眠薬は唯一の有効な治療法として見られ",組み込み製薬化"につながった.
- ユーザーは,必要性と習慣によって駆動され,使用を継続するために,積極的な (調達,貯蔵) と受動的な (レビューを避ける) 戦略を採用しました.
結論:
- 高齢者の睡眠薬の長期使用は",埋め込まれた薬剤化"のプロセスによって維持され,薬剤は感情的生活とアイデンティティの不可欠なものになります.
- 睡眠補助剤に対する必要性と感情的依存は,睡眠補助剤を減らすか避けるという表現された欲望を上回ります.
- これらの経路を理解することは,最初の処方箋を超えて薬物使用の持続性を対処するために不可欠です.
関連する概念動画
Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

